We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Essa Pharma Inc
10 own
34 watching
Current Price
$3.2
$0.09
(2.89%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
140.99M
52-Week High
14.88
52-Week Low
1.4
Average Volume
0.53M
Dividend Yield
--
P/E Ratio
--
Market Capitalization140.99M
52-Week High14.88
52-Week Low1.4
Average Volume0.53M
Dividend Yield--
P/E Ratio--
What does the Essa Pharma Inc do?
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Read More
How much money does Essa Pharma Inc make?
News & Events about Essa Pharma Inc.
PR Newswire
30days ago
Thinking about buying stock in ESSA Pharma, Meta Platforms, Nio, Quanergy Systems, or Alphabet? Thinking about buying stock in ESSA Pharma, Meta Platforms, Nio, Quanergy Systems, or Alphabet? PR Newswire NEW YORK, Oct. 28, 2022 NEW YORK, Oct. 28, 2022 /PRNewswire/ -- InvestorsObserverissues...
Zolmax
5 months ago
Woodline Partners LP increased its stake in shares of ESSA Pharma Inc. (NASDAQ:EPIX Get Rating) (TSX:EPI) by 286.6% in the 4th quarter, HoldingsChannel reports. The firm owned 684,247 shares of the companys stock after buying an additional 507,239 shares during the quarter. Woodline Partners LPs ...
Ticker Report
5 months ago
Woodline Partners LP grew its stake in ESSA Pharma Inc. (NASDAQ:EPIX Get Rating) (TSX:EPI) by 286.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 684,247 shares of the companys ...
Zolmax
6 months ago
ESSA Pharma (NASDAQ:EPIX Get Rating) (TSX:EPI) had its price objective lowered by Piper Sandler from $50.00 to $20.00 in a research report released on Thursday, The Fly reports. EPIX stock opened at $5.91 on Thursday. ESSA Pharma has a 52 week low of $5.22 and a 52 week high of $36.00. The company ...
CNW Group - News Releases
7 months ago
ESSA Pharma Announces the Presentation of Preclinical Data for its First Generation of Androgen Receptor N-Terminal Domain Degraders ESSA Pharma Announces the Presentation of Preclinical Data for its First Generation of Androgen Receptor N-Terminal Domain Degraders Canada NewsWire SOUTH SAN...
Frequently Asked Questions
Frequently Asked Questions
What is Essa Pharma Inc share price today?
plus_minus_icon
Can Indians buy Essa Pharma Inc shares?
plus_minus_icon
How can I buy Essa Pharma Inc shares from India?
plus_minus_icon
Can Fractional shares of Essa Pharma Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Essa Pharma Inc stocks?
plus_minus_icon
What is today’s traded volume of Essa Pharma Inc?
plus_minus_icon
What is today’s market capitalisation of Essa Pharma Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Essa Pharma Inc?
plus_minus_icon
What percentage is Essa Pharma Inc down from its 52-Week High?
plus_minus_icon
What percentage is Essa Pharma Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.2
$0.09
(2.89%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00